| 0 (0%) | 12-05 09:28 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 9.05 |
1-year : | 10.57 |
| Resists | First : | 7.75 |
Second : | 9.05 |
| Pivot price | 2.19 |
|||
| Supports | First : | 3.12 |
Second : | 0.26 |
| MAs | MA(5) : | 5.76 |
MA(20) : | 1.76 |
| MA(100) : | 0.77 |
MA(250) : | 0 | |
| MACD | MACD : | 1.5 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 98.2 |
D(3) : | 87.1 |
| RSI | RSI(14): 97.1 |
|||
| 52-week | High : | 7.75 | Low : | 0.25 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MBRX ] has closed below upper band by 4.0%. Bollinger Bands are 1953.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 7.76 - 7.79 | 7.79 - 7.82 |
| Low: | 7.21 - 7.24 | 7.24 - 7.27 |
| Close: | 7.65 - 7.71 | 7.71 - 7.76 |
Tue, 02 Dec 2025
12/1/2025 Market Update - Winners: MBRX, XHLD, TLRY - Losers: CETY, NVVE, LEDS - S&P 500: 0% - Trefis
Sun, 30 Nov 2025
Why Did MBRX Stock Plummet Over 25% Today? - MSN
Fri, 28 Nov 2025
Moleculin Biotech Bets Big On New Cancer Drug Trials - Finimize
Wed, 26 Nov 2025
Moleculin Announces Reverse Stock Split - Sahm
Mon, 24 Nov 2025
$MBRX stock is down 16% today. Here's what we see in our data. - Quiver Quantitative
Thu, 13 Nov 2025
Moleculin (Nasdaq: MBRX) sets Q1 2026 finish for first 45 patients; unblinding after - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 51 (M) |
| Shares Float | 50 (M) |
| Held by Insiders | 2.1 (%) |
| Held by Institutions | 4.4 (%) |
| Shares Short | 212 (K) |
| Shares Short P.Month | 157 (K) |
| EPS | -49.75 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.55 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -69.2 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.48 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -22 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | -0.16 |
| PEG Ratio | 0 |
| Price to Book value | -14.28 |
| Price to Sales | 0 |
| Price to Cash Flow | -17.49 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|